Alirocumab

Tax included
Alirocumab (REGN 727) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia.
MedChemExpress 
HY-P9928

Data sheet

Size
Multiple sizes
Reactivity
Ser/Thr Protease
Application
Metabolism-protein/nucleotide metabolism
CAS
1245916-14-6